SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-10-005118
Filing Date
2010-10-18
Accepted
2010-10-18 16:23:47
Documents
5
Period of Report
2010-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c63036_8k.htm 8-K 12690
2 c63036_ex3-1.htm EX-31.1 70207
3 c63036_ex99-1.htm EX-99.1 78026
4 GRAPHIC c63036001_v1.jpg GRAPHIC 3098
5 GRAPHIC c63036002_v1.jpg GRAPHIC 2701
  Complete submission text file 0000930413-10-005118.txt   170971
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 101128282
SIC: 8071 Services-Medical Laboratories